BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16050893)

  • 1. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of marketing interactions with medical trainees' knowledge about evidence-based prescribing: results from a national survey.
    Austad KE; Avorn J; Franklin JM; Campbell EG; Kesselheim AS
    JAMA Intern Med; 2014 Aug; 174(8):1283-90. PubMed ID: 24911123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policies regulating the activities of pharmaceutical representatives in residency programs.
    Brotzman GL; Mark DH
    J Fam Pract; 1992 Jan; 34(1):54-7. PubMed ID: 1728655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study.
    Kao AC; Braddock C; Clay M; Elliott D; Epstein SK; Filstead W; Hotze T; May W; Reenan J
    Acad Med; 2011 Nov; 86(11):1454-62. PubMed ID: 21952057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
    McCormick BB; Tomlinson G; Brill-Edwards P; Detsky AS
    JAMA; 2001 Oct 24-31; 286(16):1994-9. PubMed ID: 11667936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors.
    Lichstein PR; Turner RC; O'Brien K
    Arch Intern Med; 1992 May; 152(5):1009-13. PubMed ID: 1580704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
    Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
    CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.
    Mahood S; Zagozeski C; Bradel T; Lawrence K
    Can Fam Physician; 1997 Nov; 43():1947-51. PubMed ID: 9386881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.
    Hopper JA; Speece MW; Musial JL
    J Gen Intern Med; 1997 Oct; 12(10):639-42. PubMed ID: 9346461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical industry support and residency education: a survey of internal medicine program directors.
    Loertscher LL; Halvorsen AJ; Beasley BW; Holmboe ES; Kolars JC; McDonald FS
    Arch Intern Med; 2010 Feb; 170(4):356-62. PubMed ID: 20177039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical education and the pharmaceutical industry.
    Goodman RL
    Perspect Biol Med; 2007; 50(1):32-9. PubMed ID: 17259674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities.
    Brotzman GL; Mark DH
    J Gen Intern Med; 1993 Mar; 8(3):130-4. PubMed ID: 8455108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.